Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Gains from Investment Securities (2016 - 2026)

Viridian Therapeutics, Inc.\DE has reported Gains from Investment Securities over the past 10 years, most recently at $729000.0 for Q4 2025.

  • Quarterly results put Gains from Investment Securities at $729000.0 for Q4 2025, down 22.86% from a year ago — trailing twelve months through Dec 2025 was $1.2 million (up 146.98% YoY), and the annual figure for FY2025 was $729000.0, up 46.98%.
  • Gains from Investment Securities for Q4 2025 was $729000.0 at Viridian Therapeutics, Inc.\DE, down from $945000.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for VRDN hit a ceiling of $945000.0 in Q4 2024 and a floor of -$744000.0 in Q4 2023.
  • Median Gains from Investment Securities over the past 4 years was -$4500.0 (2021), compared with a mean of $45400.0.
  • Peak annual rise in Gains from Investment Securities hit 325.71% in 2021, while the deepest fall reached 183.72% in 2021.
  • Viridian Therapeutics, Inc.\DE's Gains from Investment Securities stood at $79000.0 in 2021, then tumbled by 1041.77% to -$744000.0 in 2023, then skyrocketed by 227.02% to $945000.0 in 2024, then decreased by 22.86% to $729000.0 in 2025.
  • The last three reported values for Gains from Investment Securities were $729000.0 (Q4 2025), $945000.0 (Q4 2024), and -$449000.0 (Q3 2024) per Business Quant data.